Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
6.86
-0.06 (-0.87%)
At close: Sep 15, 2026, 4:00 PM EDT
6.75
-0.11 (-1.60%)
After-hours: Sep 15, 2026, 7:30 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $21.87 million as of September 15, 2026. Its market cap has increased by 82.95% in one year.
Market Cap
21.87M
Enterprise Value
12.38M
1-Year Change
82.95%
Ranking
Category
Stock Price
$6.86
ChartMarket Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $21.87M, a decrease of -87.32%. That is a compound annual growth rate of -30.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 21.87M | 102.61% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.98% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 25.05M |
| Tvardi Therapeutics | 24.94M |
| Radiopharm Theranostics | 24.89M |
| Cocrystal Pharma | 23.89M |
| NanoViricides | 23.24M |
| Polyrizon | 23.21M |
| Akari Therapeutics, | 22.00M |
| Jasper Therapeutics | 21.97M |